87 related articles for article (PubMed ID: 28290042)
21. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
22. Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.
Mudgil M; Pawar PK
Sci Pharm; 2013; 81(2):591-606. PubMed ID: 23833723
[TBL] [Abstract][Full Text] [Related]
23. Desloratadine-Eudragit
Yenilmez E
Turk J Pharm Sci; 2017 Aug; 14(2):148-156. PubMed ID: 32454606
[TBL] [Abstract][Full Text] [Related]
24. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
[TBL] [Abstract][Full Text] [Related]
25. Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization.
Payab S; Davaran S; Tanhaei A; Fayyazi B; Jahangiri A; Farzaneh A; Adibkia K
Artif Cells Nanomed Biotechnol; 2016; 44(1):362-9. PubMed ID: 25180944
[TBL] [Abstract][Full Text] [Related]
26. Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS).
Friedrich I; Reichl S; Müller-Goymann CC
Int J Pharm; 2005 Nov; 305(1-2):167-75. PubMed ID: 16242276
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
[TBL] [Abstract][Full Text] [Related]
28. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.
Abrego G; Alvarado HL; Egea MA; Gonzalez-Mira E; Calpena AC; Garcia ML
J Pharm Sci; 2014 Oct; 103(10):3153-64. PubMed ID: 25091511
[TBL] [Abstract][Full Text] [Related]
29. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
Ali HS; York P; Ali AM; Blagden N
J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
[TBL] [Abstract][Full Text] [Related]
30. Statistical Optimization of Oral Vancomycin-Eudragit RS Nanoparticles Using Response Surface Methodology.
Delf Loveymi B; Jelvehgari M; Zakeri-Milani P; Valizadeh H
Iran J Pharm Res; 2012; 11(4):1001-12. PubMed ID: 24250531
[TBL] [Abstract][Full Text] [Related]
31. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
[TBL] [Abstract][Full Text] [Related]
32. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
[TBL] [Abstract][Full Text] [Related]
33. Preparation and Evaluation of Eudragit® L100 Nanoparticles Loaded Impregnated with KT Tromethamine Loaded PVA -HEC Insertions for Ophthalmic Drug Delivery.
Mohammadi G; Mirzaeei S; Taghe S; Mohammadi P
Adv Pharm Bull; 2019 Oct; 9(4):593-600. PubMed ID: 31857963
[No Abstract] [Full Text] [Related]
34. Preparation of azithromycin nanosuspensions by reactive precipitation method.
Hou CD; Wang JX; Le Y; Zou HK; Zhao H
Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
[TBL] [Abstract][Full Text] [Related]
35. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres.
Devrim B; Bozkir A; Canefe K
Acta Pol Pharm; 2011; 68(4):593-9. PubMed ID: 21796942
[TBL] [Abstract][Full Text] [Related]
36. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
[TBL] [Abstract][Full Text] [Related]
37. Eudragit FS based colonic microparticls of metoprolol tartrate.
Rasool F; Ahmad M; Murtaza G; Khan HM; Khan SA
Acta Pol Pharm; 2012; 69(2):347-53. PubMed ID: 22568051
[TBL] [Abstract][Full Text] [Related]
38. A novel nanoparticulate system for sustained delivery of acid-labile lansoprazole.
Alai MS; Lin WJ
Colloids Surf B Biointerfaces; 2013 Nov; 111():453-9. PubMed ID: 23867305
[TBL] [Abstract][Full Text] [Related]
39. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
Shenoy D; Little S; Langer R; Amiji M
Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
[TBL] [Abstract][Full Text] [Related]
40. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
